![]()
MIRA INFORM
REPORT
|
Report Date : |
24.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
COSMOS LIMITED |
|
|
|
|
Registered Office : |
Plot No.LR/7419, Rangwe Close Off |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
13.10.1996 |
|
|
|
|
Com. Reg. No.: |
C5676 |
|
|
|
|
Legal Form : |
Limited Corporation |
|
|
|
|
Line of Business : |
Manufacture and distribution of pharmaceuticals
including veterinary medicines |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Registered Name: COSMOS LIMITED
Requested Name: COSMOS
LIMITED
Other Names: None
Physical Address: Plot
no.LR/7419, Rangwe close off
Postal Address:
Country:
Phone: 254-20-550680/
532948/ 550700-09
Fax: 254-20-550680/532948
Email: info@cosmos-pharm.com
Website: www.cosmos-pharm.com
Financial Index as of
December 2010 shows subject firm with a medium risk of credit. However, bank
and credit information obtained reveal a history of prompt payments. We
recommend Credit of USD 150,000 on 90 days.
Legal Form: Limited Corporation
Date Incorporated: 13-Oct-1996
Reg. Number: C5676
Tax Number: P000609319W
Nominal Capital KES. 100,000,000 Divided into
Shares of 100,000 each KES.100
Subscribed Capital KES. 60,910,000
Subscribed Capital is Subscribed in the following form:
Position Shares
Dr. Prakash K. Patel MD/ CEO 243,700
Mr. Gaurang P. Patel Director 121,800
Mr. Vimal P. Patel Director 121,800
Mr. Laxman K.
Varsani Director 121,800
None Parent company.
None Subsidiary company.
None Affiliated company.
Pharmevet Limited U.K Shareholder of subject firm.
None Branches of the firm
Registered to operate manufacture and distribution of pharmaceuticals
including veterinary medicines
Imports: Europe,
Exports:
Trademarks: Cosmos
Terms
of sale: Cash (40%) and 30
days (60%), invoices.
Main
Customers: Individuals, firms
and organizations
Employees: 340 employees.
Vehicles: Several motor
vehicles.
Territory
of sales:
Location: Rented premises
100,000 square feet
Auditors: V.A. PATEL,
Insurance
Brokers: JUBILEE ASSURANCE
Currency Reported:
Approx. Ex. Rate: 1 US Dollar = 81.85
Fiscal
Year End: December 31, 2010
Inflation: According to
information given by independent sources, the
inflation
at December 31st, 2010 was of 13%.
Financial Information not Submitted
Profit and Loss (expressed in KES.)
2009 2010
Sales 842,254,174 1,000,000,000
Net Profit (Loss) 64,250,000 86,285,000
Bank Name: BARCLAYS BANK OF KENYA LIMITED
Branch:
Comments: Good
Experiences: Good
None
This information was obtained from outside sources other than the
subject company itself and confirmed the above subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.20 |
|
|
1 |
Rs.73.17 |
|
Euro |
1 |
Rs.61.88 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.